These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 23343901)

  • 21. [Trazodon--the antidepressant: mechanism of action and its position in the treatment of depression].
    Jarema M; Dudek D; Landowski J; Heitzman J; Rabe-Jabłońska J; Rybakowski J
    Psychiatr Pol; 2011; 45(4):611-25. PubMed ID: 22232986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacology of antidepressants: focus on nefazodone.
    DeVane CL; Grothe DR; Smith SL
    J Clin Psychiatry; 2002; 63 Suppl 1():10-7. PubMed ID: 11890560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical use of nefazodone in major depression: a 6-year perspective.
    Schatzberg AF; Prather MR; Keller MB; Rush AJ; Laird LK; Wright CW
    J Clin Psychiatry; 2002; 63 Suppl 1():18-31. PubMed ID: 11890561
    [No Abstract]   [Full Text] [Related]  

  • 24. Spotlight on paroxetine in psychiatric disorders in adults.
    Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
    CNS Drugs; 2002; 16(6):425-34. PubMed ID: 12027788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacology of rapid-onset antidepressant treatment strategies.
    Blier P
    J Clin Psychiatry; 2001; 62 Suppl 15():12-7. PubMed ID: 11444761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain Histamine Is Crucial for Selective Serotonin Reuptake Inhibitors' Behavioral and Neurochemical Effects.
    Munari L; Provensi G; Passani MB; Galeotti N; Cassano T; Benetti F; Corradetti R; Blandina P
    Int J Neuropsychopharmacol; 2015 Apr; 18(10):pyv045. PubMed ID: 25899065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New drugs for old folks: the evidence-based argument for newer antidepressants.
    Kennedy GJ
    J Am Geriatr Soc; 2001 Feb; 49(2):227-8. PubMed ID: 11207879
    [No Abstract]   [Full Text] [Related]  

  • 28. [Citalopram].
    El-Armouche A; Zolk O; Eschenhagen T
    Dtsch Med Wochenschr; 2003 Oct; 128(43):2253-6. PubMed ID: 14574639
    [No Abstract]   [Full Text] [Related]  

  • 29. [Mirtazapine versus other antidepressive agents for depression].
    Knud Larsen J
    Ugeskr Laeger; 2012 Nov; 174(46):2864-6. PubMed ID: 23153468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical resource use and cost of venlafaxine or tricyclic antidepressant therapy. Following selective serotonin reuptake inhibitor therapy for depression.
    Griffiths RI; Sullivan EM; Frank RG; Strauss MJ; Herbert RJ; Clouse J; Goldman HH
    Pharmacoeconomics; 1999 May; 15(5):495-505. PubMed ID: 10537966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venlafaxine: a novel antidepressant that has a dual mechanism of action.
    Andrews JM; Ninan PT; Nemeroff CB
    Depression; 1996; 4(2):48-56. PubMed ID: 9160640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressant options: venlafaxine in perspective.
    Thase ME
    J Clin Psychopharmacol; 1996 Jun; 16(3 Suppl 2):10S-18S; discussion 18S-20S. PubMed ID: 8784644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?
    Sanchez C; Reines EH; Montgomery SA
    Int Clin Psychopharmacol; 2014 Jul; 29(4):185-96. PubMed ID: 24424469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychopharmacology. Volatile chemistry: children and antidepressants.
    Couzin J
    Science; 2004 Jul; 305(5683):468-70. PubMed ID: 15273374
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.
    Sussman N; Ginsberg DL; Bikoff J
    J Clin Psychiatry; 2001 Apr; 62(4):256-60. PubMed ID: 11379839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Controlled long-term prevention of unipolar depression with antidepressive agents of the second generation (SSRI)].
    Zimmermann U
    Psychiatr Prax; 1996 Sep; 23(5):240-3. PubMed ID: 8992518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of new antidepressants.
    Sambunaris A; Hesselink JK; Pinder R; Panagides J; Stahl SM
    J Clin Psychiatry; 1997; 58 Suppl 6():40-53. PubMed ID: 9227672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Questions about SSRI antidepressant drug regulation.
    Hay A
    Lancet; 2004 Aug 14-20; 364(9434):577. PubMed ID: 15313347
    [No Abstract]   [Full Text] [Related]  

  • 39. [Why lie about the causes of depression?].
    Mulinari S
    Lakartidningen; 2011 Sep 21-27; 108(38):1839-40. PubMed ID: 22111217
    [No Abstract]   [Full Text] [Related]  

  • 40. Psychobiology and psychopharmacotherapy of unipolar major depression: a review.
    O'Toole SM; Johnson DA
    Arch Psychiatr Nurs; 1997 Dec; 11(6):304-13. PubMed ID: 9419922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.